Trial Profile
A phase II trial of EVT 401 in patients with rheumatoid arthritis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs EVT 401 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Evotec SE
- 07 Jul 2009 New trial record.